Prevalence and relationship between diabetic and nephropathy, and its risk factors in the north-east of Spain, a population-based study

Ophthalmic Epidemiology

Volumn 17, Issue 4, 2010, Pages 251-265

  Pedro, Romero Aroca ^a   Ramon, Sagarra Alamo ^b   Marc, Baget Bernaldiz ^a   Juan, Fernández Ballart ^c   Isabel, Méndez Marin ^a  

^a HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

^b Primary Care Health Area Reus Priorat   (Spain)

^c UNIVERSITAT ROVIRA I VIRGILI   (Spain)

Author keywords

Diabetic macular edema; Diabetic retinopathy; Epidemiological study; Microalbuminuria; Overt nephropathy; Prevalence; TC HDL ratio

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; DISEASE REGISTRY; ETHICS; FEMALE; HUMAN; HYPERTENSION; INFORMED CONSENT; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; KIDNEY DISEASE; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MICROANGIOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; RETINA MACULA EDEMA; RISK FACTOR; SCHOOL CHILD; SPAIN; STATISTICAL SIGNIFICANCE; VISUAL ACUITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALBUMINURIA; CHILD; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; FEMALE; HUMANS; MACULAR EDEMA; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SPAIN; VISUAL ACUITY;

EID: 77954851304     PISSN: 09286586     EISSN: 17445086     Source Type: Journal    
DOI: 10.3109/09286586.2010.498661     Document Type: Article

References (40)

1. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21(9):1414-1431.
2. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2000). Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 23:S4-S19.
3. Geiss L, Engelgau M, Fraizer E, Tierney E. Diabetes surveillance, 1997. Centers for Disease Control and Prevention. U.S. Department of Health and Human Services Atlanta GA. 1997.
4. Diabetes Control and Complications trial/Epidemiology of Diabetes Interventions and Complications Research Group. Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus. Arch Ophthalmology. 2008;126(12):1707-1715.
5. Kohner EM, Aldington SJ, Stratton IM, Manley SE, Holman RR, Turner RC. United Kingdom Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of non-insulindependent diabetes mellitus and associated risk factors. Arch Ophthalmol. 1998;116(3):297-303.
6. Consell Assesor sobre Diabetes a Catalunya. Registre de diabetes tipus 1 de Catalunya, 1995-2002. Butlleti EpidemioLic de Catalunya. Vol XXIII, num 4. Barcelona. Departament de Sanitat i Seguretat Social, 2002.
7. Castell C, Tresserras R, Lloveras G, Goday A, Serra J, Salleras L. Prevalence of diabetes in Catalonia, an OGTTbased population study. Diab Res Clin Prac. 1999;43(1): 33-40.
8. Aldington SJ, Kohner EM, Meuer S, Klein R, Sjolie AK. Methodology for retinal photography and assessment of diabetic retinopathy, The EURODIAB IDDM complications study. Diabetologia. 1995;38(4):437-444.
9. Wilkinson CP, Ferris FL 3rd, Klein RE, Lee PP, Agardh CD, Davis M, Dills D, Kampik A, Pararajasegaram R, Verdaguer JT; Global Diabetic Retinopathy Project Group. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003;110(9):1677-1682.
10. ETDRS. Detection of diabetic macular edema study n-5. Ophthalmology. 1989;96:746-751.
11. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation and treatment of High Blood Pressure. Arch Intern Med. 1997;157(21):2413-2442.
12. American Diabetes Association. Clinical practicerecommendations. Diabetes Care. 2002;25, suppl 1.
13. European Diabetes Policy Group. A Desktop guide to type I (insulin-dependent) diabetes mellitus 1998-199. Guidelines for diabetes care. Diabetic Med. 1999; 16(3):253-266.
14. American Diabetes Association. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997;20:1183-1201.
15. Mogensen CE, Christensen CK, Vittinghus E. The stages in diabetic renal disease, with emphasis on the stage of incipient diabetic nephropathy. Diabetes. 1983;32 Suppl 2:64-78.
16. Expert Panel on Detection, Evaluation, And Treatment of high Blood Cholesterol in Adults (Adult Treatment Panel III). Executive summary of the third report of the National Cholesterol Education Program (NCEP). JAMA. 2001;285:2486-2497.
17. Rifai N, Ridker PM. Proposed cardiovascular risk assessment algorithm using high-sensitivity C-reactive protein and lipid screening. Clin Chem. 2001;47(1):28-30.
18. Romero-Aroca P, del Castillo-Dardin D. Estudio de prevalencia de retinopaT diabica en la poblacidel Baix Camp (Tarragona). Arch Soc Esp Oftalmol. 1996;71:261-268.
19. Lez IM, Dz A, Velilla S, Rueda A, Alvarez A, Pastor CJ. Prevalence of diabetic retinopathy and eye care in a rural area of Spain. Ophthalmic Epidemiol. 2002;9(3):205-214.
20. Santos-Bueso E, Fern-dez-Vigo J, Fern-dez-Pez C, Macarro- Merino A, Fern-dez-Perianes J. Prevalencia de retinopaT diabica en la Comunidad AuToma de Extremadura. 1997-2001 (Proyecto Extremadura para prevencide la ceguera). Arch Soc Esp Oftalmol. 2005;80(3):187-194.
21. Teruel-Macias C, Fern-dez-Real JM, Ricart W, Valent- Ferrer R, ValL-Prats M.Prevalencia de la retinopaT diabica en la poblacide diabicos diagnosticados en las comarcas de Girona. Estudio de los factores asociados. Arch Soc Esp Oftalmol. 2005;80(3):85-91
22. Davis TM, Stratton IM, Fox CJ, Holman RR, Turner RC. UK Prospective Diabetes Study 22. Effect of age at diagnosis on diabetic tissue damage during the first 6 years of NIDDM. Diabetes Care. 1997;20 (9):1435-1441.
23. Lundman B, Engstrom L. Diabetes and it's complications in a Swedish county. Diabetes Res Clin Pract. 1998;39 (2): 157-164.
24. Toeller M, Buyken AE, Heitkamp G, Berg G, Scherbaum WA.Prevalence of chronic complications, metabolic control and nutritional intake in type I diabetes: comparison between different European regions. EURODIAB Complications Study group. Horm Metab Res. 1999;31:680-685.
25. Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology. 1998;105(10):1801-1815.
26. Klein R, Moss SE, Klein BE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. XI. The incidence of macular edema. Ophthalmology. 1989;96(10):1501-1510. (Pubitemid 19250961)
27. Klein BE, Moss SE, Klein R, Surawicz TS: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XIII. Relationship of serum cholesterol to retinopathy and hard exudate. Ophthalmology. 1991;98:1261-1265.
28. Klein BE, Klein R, Moss SE. Is serum cholesterol associated with progression of diabetic retinopathy or macular edema in persons with younger onset diabetes of long duration. Am J Ophthalmol. 1999;128(5):652-654.
29. Chew EY, Klein ML, Ferris FL 3rd, Remaley NA, Murphy RP, Chantry K, Hoogwerf BJ, Miller D. Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy: Early Treatment Diabetic Retinopathy Study (ETDRS) report 22. Arch Ophthalmol. 1996;114(9):1079-1084.
30. MilL J, PinTX, Müz A, et al. Lipoprotein ratios: Physiological significance and clinical usefulness in cardiovascular prevention. Vasc Health Risk Manag. 2009;5:757-765
31. Mohan R, Mohan V, Susheela L, Ramachandran A, Viswanathan M. Increased LDL cholesterol in non-insulin-dependent diabetics with maculopathy. Acta Diabetol Lat. 1984;21(1):85-89.
32. Landmesser U, Hornig B, Drexler H. Endothelial dysfunction in hypercholesterolemia: mechanisms, pathophysiological importance, and therapeutic interventions. Semin Thromb Hemost. 2000;26(5):529-537.
33. Joussen AM, Murata T, Tsujikawa A, Kirchhof B, Bursell SE, Adamis AP. Leukocyte mediated endothelial cell injury and death in the diabetic retina. Am J Pathol. 2001;158(1):147-152.
34. Joussen AM, Poulaki V, Mitsiades N, et al. Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression. FASEB J. 2002;16(3):438-440.
35. Brancati FL, Cusumano AM. Epidemiology and prevention of diabetic nephropathy. Current Opinion in Nephrolology and Hypertension. 1995;4(3):223-229.
36. Jawa A, Kcomt J, Fonseca VA. Diabetic nephropathy and retinopathy. Med Clin N Am. 2004;88(4):1001-1036.
37. Hovind P, Tarnow L, Rossing K, Rossing P, Eising S, Larsen N, Binder C, Parving HH. Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. Diabetes Care. 2003;26(4):1258-1264.
38. Rossi MC, Nicolucci A, Pellegrini F, et al. Identifying patients with type 2 diabetes at high risk of microalbuminuria: results of the DEMAND (Developing Education on Microalbuminuria for Awareness of Renal and cardiovascular risk in Diabetes) Study. Nephrol Dial Transplant. 2008;23(4):1278-1284.
39. Skrivarhaug T, Bangstad HJ, Stene LC, Sandvik L, Hanssen KF, Joner G. Low risk of overt nephropathy after 24 yr of childhood-onset type 1 diabetes mellitus (T1DM) in Norway. Pediatr Diabetes. 2006;7(5):239-246.
40. Pambianco G, Costacou T, Ellis D, Becker DJ, Klein R, Orchard TJ. The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes. 2006;55(5):1463-1469. (Pubitemid 44195388)